November 24, 2012 at 05:34 AM EST
Week in Review: Henan Province Starts $40 Million Biological Fund
The Henan Broadhi Biological Fund was established with 250 million RMB ($40 million) of venture capital to support biological companies in Henan Province; ShanghaiTech University announced the formation of the iHuman Institute, an international basic science research effort that will focus on cell signaling and kinases; Hebei Changshan Biochemical Pharma will form a JV with ConjuChem, a privately owned Los Angeles company that is developing a long-acting form of insulin; Sihuan Pharma, China’s largest cerebral-cardiovascular drugmaker, bought China rights to two clinical-stage drugs from NeuroVive Pharmaceutical; and Hua Medicine is on track to start clinical trials of a treatment for type 2 diabetes in-licensed from Roche. More details…. Stock Symbols: (SHE: 300255) (HK: 0460) (SIX: ROG) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here